Selectivity through discriminatory induced fit enables switching of NAD(P)H coenzyme specificity in Old Yellow Enzyme ene-reductases.


Journal

The FEBS journal
ISSN: 1742-4658
Titre abrégé: FEBS J
Pays: England
ID NLM: 101229646

Informations de publication

Date de publication:
08 2019
Historique:
received: 15 02 2019
revised: 22 03 2019
accepted: 24 04 2019
pubmed: 30 4 2019
medline: 22 5 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

Most ene-reductases belong to the Old Yellow Enzyme (OYE) family of flavin-dependent oxidoreductases. OYEs use nicotinamide coenzymes as hydride donors to catalyze the reduction of alkenes that contain an electron-withdrawing group. There have been many investigations of the structures and catalytic mechanisms of OYEs. However, the origin of coenzyme specificity in the OYE family is unknown. Structural NMR and X-ray crystallographic data were used to rationally design variants of two OYEs, pentaerythritol tetranitrate reductase (PETNR) and morphinone reductase (MR), to discover the basis of coenzyme selectivity. PETNR has dual-specificity and reacts with NADH and NADPH; MR accepts only NADH as hydride donor. Variants of a β-hairpin motif in an active site loop of both these enzymes were studied using stopped-flow spectroscopy. Specific attention was placed on the potential role of arginine residues within the β-hairpin motif. Mutagenesis demonstrated that Arg130 governs the preference of PETNR for NADPH, and that Arg142 interacts with the coenzyme pyrophosphate group. These observations were used to switch coenzyme specificity in MR by replacing either Glu134 or Leu146 with arginine residues. These variants had increased (~15-fold) affinity for NADH. Mutagenesis enabled MR to accept NADPH as a hydride donor, with E134R MR showing a significant (55-fold) increase in efficiency in the reductive half-reaction, when compared to the essentially unreactive wild-type enzyme. Insight into the question of coenzyme selectivity in OYEs has therefore been addressed through rational redesign. This should enable coenzyme selectivity to be improved and switched in other OYEs.

Identifiants

pubmed: 31033202
doi: 10.1111/febs.14862
pmc: PMC6767020
doi:

Substances chimiques

Bacterial Proteins 0
Coenzymes 0
NADP 53-59-8
Arginine 94ZLA3W45F
Oxidoreductases EC 1.-
morphinone reductase EC 1.3.1.-
NADPH Dehydrogenase EC 1.6.99.1
pentaerythritol tetranitrate reductase EC 1.7.99.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3117-3128

Subventions

Organisme : EU's Seventh Framework Programme (Marie Curie Initial Training Network, MAGIC)
ID : 606831
Pays : International
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M007065/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N013980/1
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

FEBS Lett. 2001 Mar 16;492(3):193-8
pubmed: 11257493
J Biol Chem. 2002 Aug 23;277(34):30976-83
pubmed: 12048188
Microbiology. 2002 Jun;148(Pt 6):1607-14
pubmed: 12055282
J Biol Chem. 2003 Nov 7;278(45):43973-82
pubmed: 12941965
Appl Environ Microbiol. 2004 Jun;70(6):3566-74
pubmed: 15184158
Biochem J. 2006 Feb 15;394(Pt 1):335-44
pubmed: 16293111
Anal Biochem. 2006 May 15;352(2):282-5
pubmed: 16574057
Curr Opin Chem Biol. 2007 Apr;11(2):203-13
pubmed: 17353140
J Am Chem Soc. 2007 Nov 14;129(45):13949-56
pubmed: 17939663
FEBS J. 2009 Sep;276(17):4780-9
pubmed: 19664062
J Am Chem Soc. 2009 Dec 2;131(47):17072-3
pubmed: 19891489
Chembiochem. 2010 Nov 22;11(17):2433-47
pubmed: 21064170
Trends Biotechnol. 2011 Jan;29(1):18-25
pubmed: 21087800
Tetrahedron. 2010 Jan 16;66(3-2):663-667
pubmed: 21270958
Chembiochem. 2011 Mar 21;12(5):738-49
pubmed: 21374779
Biochemistry. 1990 Jul 17;29(28):6609-18
pubmed: 2204417
Bioresour Technol. 2012 Jul;115:196-207
pubmed: 22230779
Chem Soc Rev. 2012 Feb 21;41(4):1585-605
pubmed: 22234546
Nature. 1990 Jan 4;343(6253):38-43
pubmed: 2296288
Org Lett. 2013 Jan 4;15(1):180-3
pubmed: 23256747
J Am Chem Soc. 2013 Feb 20;135(7):2512-7
pubmed: 23373704
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W597-600
pubmed: 23671338
J Am Chem Soc. 2013 Sep 25;135(38):14425-32
pubmed: 23987134
Curr Opin Chem Biol. 2014 Apr;19:107-15
pubmed: 24608082
J Biotechnol. 2014 Dec 20;192 Pt B:393-9
pubmed: 24746588
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
Methods Mol Biol. 2014;1146:161-75
pubmed: 24764092
J Biotechnol. 2014 Dec 10;191:22-31
pubmed: 25102236
Org Biomol Chem. 2015 Jan 7;13(1):223-33
pubmed: 25372591
Chembiochem. 2015 Feb 9;16(3):440-5
pubmed: 25639703
ACS Catal. 2015 Feb 6;5(2):892-899
pubmed: 25692074
Biotechnol Adv. 2015 Sep-Oct;33(5):624-31
pubmed: 25940546
J Am Chem Soc. 2016 Jan 27;138(3):1033-9
pubmed: 26727612
Catal Sci Technol. 2016 Jan 7;6(1):169-177
pubmed: 27019691
Chembiochem. 2016 Apr 1;17(7):561-5
pubmed: 27037735
ACS Synth Biol. 2017 Feb 17;6(2):326-333
pubmed: 27648601
Chembiochem. 2017 Apr 4;18(7):685-691
pubmed: 28107586
Org Biomol Chem. 2017 May 23;15(20):4440-4448
pubmed: 28485453
Angew Chem Int Ed Engl. 2017 Jul 17;56(30):8681-8685
pubmed: 28544039
Biomol NMR Assign. 2018 Apr;12(1):79-83
pubmed: 29168057
Curr Opin Chem Biol. 2018 Apr;43:97-105
pubmed: 29275291
Nature. 2018 Aug;560(7718):355-359
pubmed: 30111790
ACS Catal. 2018 Dec 7;8(12):11589-11599
pubmed: 31119061
ACS Catal. 2019 May 15;7(5):3190-3198
pubmed: 31157122
ACS Catal. 2019 May 15;8(4):3532-3549
pubmed: 31157123
J Bacteriol. 1972 Jul;111(1):24-32
pubmed: 4360220
Protein Sci. 1994 Sep;3(9):1504-14
pubmed: 7833810
Biochem J. 1994 Jul 1;301 ( Pt 1):97-103
pubmed: 8037698
J Bacteriol. 1996 Nov;178(22):6623-7
pubmed: 8932320
J Bacteriol. 1997 Dec;179(24):7796-802
pubmed: 9401040

Auteurs

Andreea I Iorgu (AI)

Manchester Institute of Biotechnology and School of Chemistry, Faculty of Science and Engineering, The University of Manchester, UK.

Tobias M Hedison (TM)

Manchester Institute of Biotechnology and School of Chemistry, Faculty of Science and Engineering, The University of Manchester, UK.

Sam Hay (S)

Manchester Institute of Biotechnology and School of Chemistry, Faculty of Science and Engineering, The University of Manchester, UK.

Nigel S Scrutton (NS)

Manchester Institute of Biotechnology and School of Chemistry, Faculty of Science and Engineering, The University of Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH